Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2008 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting

Study NCT00004128 Information provided by National Cancer Institute (NCI)

First Received on December 10, 1999. Last Updated on December 22, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia

Additional conditions recognized in this trial

Leukemia, Myeloid
Leukemia, Myeloid, Acute

More general conditions related to this trial

Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

aldesleukin
filgrastim
busulfan
cyclophosphamide
cytarabine
daunorubicin hydrochloride
etoposide
radiation therapy

Additional drug interventions recognized in this trial

Daunorubicin
Lenograstim

Sponsors listed in this trial

European Organisation for Research and Treatment of Cancer - EORTC
Gruppo Italiano Malattie EMatologiche dell'Adulto

Back to top of Main Content